[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.216.242. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1982

Long-term Pimozide Pretreatment Differentially Affects Behavioral Responses to Dextroamphetamine in SchizophreniaFurther Exploration of the Dopamine Hypothesis of Schizophrenia

Author Affiliations

From the Section on Neuropsychopharmacology, Biological Psychiatry Branch, National Institute of Mental Health (NIMH), Bethesda, Md. Dr Docherty is now with the Psychosocial Treatment Research Branch, NIMH. Dr Marder is now with the Veterans Administration Hospital/Brentwood, Los Angeles. Ms Rayner is now with Westat, Inc, Bethesda.

Arch Gen Psychiatry. 1982;39(3):275-281. doi:10.1001/archpsyc.1982.04290030017003
Abstract

• In ten of 30 schizophrenic patients treated with pimozide for five weeks, 20 mg of dextroamphetamine sulfate induced an increase in psychosis. The number of patients becoming more psychotic with the dextroamphetamine challenge was not significantly different from the number who worsened after dextroamphetamine challenge when pretreated with placebo. Half of the patients who showed a psychotic response to dextroamphetamine during placebo pretreatment responded to dextroamphetamine with an increase in psychosis after pimozide treatment. Dextroamphetamine induced a worsening in patients who had improved with pimozide. The stability of the preinfusion condition is more important to the type of response to dextroamphetamine than long-term pretreatment with a dopamine receptor blocker. The activation-euphoria response to dextroamphetamine was unaffected by pimozide pretreatment, which suggests that the changes in psychosis and activation may be regulated by different mechanisms. These findings question the postulated relationship between the antipsychotic drug response and dopamine receptor blockade.

×